134 related articles for article (PubMed ID: 18448430)
1. The structure and interactions of the proline-rich domain of ASPP2.
Rotem S; Katz C; Benyamini H; Lebendiker M; Veprintsev D; RĂ¼diger S; Danieli T; Friedler A
J Biol Chem; 2008 Jul; 283(27):18990-9. PubMed ID: 18448430
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.
Rotem-Bamberger S; Katz C; Friedler A
PLoS One; 2013; 8(3):e58470. PubMed ID: 23472201
[TBL] [Abstract][Full Text] [Related]
3. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2.
Rotem S; Katz C; Friedler A
Biochem Soc Trans; 2007 Nov; 35(Pt 5):966-9. PubMed ID: 17956256
[TBL] [Abstract][Full Text] [Related]
4. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
Benyamini H; Friedler A
J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
[TBL] [Abstract][Full Text] [Related]
5. A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism.
Benyamini H; Leonov H; Rotem S; Katz C; Arkin IT; Friedler A
Proteins; 2009 Nov; 77(3):602-11. PubMed ID: 19507243
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2.
Katz C; Benyamini H; Rotem S; Lebendiker M; Danieli T; Iosub A; Refaely H; Dines M; Bronner V; Bravman T; Shalev DE; RĂ¼diger S; Friedler A
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12277-82. PubMed ID: 18719108
[TBL] [Abstract][Full Text] [Related]
7. Highly homologous proteins exert opposite biological activities by using different interaction interfaces.
Amir AI; van Rosmalen M; Mayer G; Lebendiker M; Danieli T; Friedler A
Sci Rep; 2015 Jul; 5():11629. PubMed ID: 26130271
[TBL] [Abstract][Full Text] [Related]
8. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.
Ahn J; Byeon IL; Byeon CH; Gronenborn AM
J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451
[TBL] [Abstract][Full Text] [Related]
9. Aspp2 negatively regulates body growth but not developmental timing by modulating IRS signaling in zebrafish embryos.
Liu C; Luan J; Bai Y; Li Y; Lu L; Liu Y; Hakuno F; Takahashi S; Duan C; Zhou J
Gen Comp Endocrinol; 2014 Feb; 197():82-91. PubMed ID: 24362258
[TBL] [Abstract][Full Text] [Related]
10. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
Gorina S; Pavletich NP
Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
[TBL] [Abstract][Full Text] [Related]
11. The Binding of Syndapin SH3 Domain to Dynamin Proline-rich Domain Involves Short and Long Distance Elements.
Luo L; Xue J; Kwan A; Gamsjaeger R; Wielens J; von Kleist L; Cubeddu L; Guo Z; Stow JL; Parker MW; Mackay JP; Robinson PJ
J Biol Chem; 2016 Apr; 291(18):9411-24. PubMed ID: 26893375
[TBL] [Abstract][Full Text] [Related]
12. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
13. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
14. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
Chan DC; Bedford MT; Leder P
EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
[TBL] [Abstract][Full Text] [Related]
15. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.
Bedford MT; Chan DC; Leder P
EMBO J; 1997 May; 16(9):2376-83. PubMed ID: 9171351
[TBL] [Abstract][Full Text] [Related]
16. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
Robinson RA; Lu X; Jones EY; Siebold C
Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
[TBL] [Abstract][Full Text] [Related]
19. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
20. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]